Imatinib, also called Gleevec, is used in chemotherapy to treat diseases such as cancer, chronic myelogenous leukemia (CML), and acute lymphocytic leukemia (ALL). It is a drug that works. Gleevec is the brand name of imatinib sold by Novartis in Switzerland. Imatinib was approved for use in the United States in 2001, and is currently registered as an essential medicine by the World Health Organization (WHO).
Read More- https://www.medixocentre.com/gleevec-imatinib-price
Read More- https://www.medixocentre.com/gleevec-imatinib-price
Imatinib, also called Gleevec, is used in chemotherapy to treat diseases such as cancer, chronic myelogenous leukemia (CML), and acute lymphocytic leukemia (ALL). It is a drug that works. Gleevec is the brand name of imatinib sold by Novartis in Switzerland. Imatinib was approved for use in the United States in 2001, and is currently registered as an essential medicine by the World Health Organization (WHO).
Read More- https://www.medixocentre.com/gleevec-imatinib-price
0 Comments
0 Shares
368 Views